Qinghai Spring Medicinal Resources Technology Co., Ltd. (SHA:600381)

SHA:600381 Revenue

Qinghai Spring Medicinal Resources Technology had revenue of 43.80M CNY in the quarter ending March 31, 2026, a decrease of -47.58%. This brings the company's revenue in the last twelve months to 303.67M, up 12.75% year-over-year. In the year 2025, Qinghai Spring Medicinal Resources Technology had annual revenue of 343.42M with 27.07% growth.

• Revenue (ttm): 303.67M
• Revenue Growth: +12.75%
• P/S Ratio: 8.99
• Revenue / Employee: 1.91M
• Employees: 159
• Market Cap: 2.73B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	343.42M	73.16M	27.07%
Dec 31, 2024	270.26M	56.39M	26.36%
Dec 31, 2023	213.88M	53.70M	33.52%
Dec 31, 2022	160.18M	32.41M	25.37%
Dec 31, 2021	127.76M	3.50M	2.81%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 17, 2026

Data Sources Report a data error